Calea UK edges upwards

Calea UK, the home healthcare business owned by Fresenius, major provider of dialysis services, reported a 5% rise in turnover for the year to 31 December 2012 to £22.9m (2011: £21.9m).Cost of sales were £18.0m (2011: £15.7m), distribution costs £1.3m (2011: £1.4m) and administrative expenses £2.7m (2011: £4.0m) leading to a profit on ordinary activities…

Membership Required

You must be a HM Subscriber to view this content.

Subscribe Now »

Already have an account?